Next Article in Journal
Next Article in Special Issue
Previous Article in Journal
Previous Article in Special Issue
Diagnostics 2013, 3(2), 283-290; doi:10.3390/diagnostics3020283
Article

Overview of Five-Years of Experience Performing Non-Invasive Fetal Sex Assessment in Maternal Blood

1,2
, 1,2
, 1,2
, 1,2
, 1,2
, 1,2
, 3
 and 1,2,*
Received: 15 March 2013; in revised form: 26 April 2013 / Accepted: 6 May 2013 / Published: 15 May 2013
(This article belongs to the Special Issue Advance in Prenatal Diagnosis)
View Full-Text   |   Download PDF [186 KB, updated 16 May 2013; original version uploaded 15 May 2013]
Abstract: Since the discovery of the presence of fetal DNA in maternal blood, non-invasive fetal sex determination has been the test most widely translated into clinical practice. To date there is no agreement between the different laboratories performing such tests in relation to which is the best protocol. As a consequence there are almost as many protocols as laboratories offering the service, using different methodologies and thus obtaining different diagnostic accuracies. By the end of 2007, after a validation study performed in 316 maternal samples collected between the 5th and 12th week of gestation, the fetal sex determination was incorporated into clinical practice in our Service. The test is performed in the first trimester of pregnancy, and it is offered as part of the genetic counseling process for couples at risk of X-linked disorders. As a general rule and in order to avoid misdiagnosis, two samples at different gestational ages are tested per patient. The analysis is performed by the study of the SRY gene by RT-PCR. Two hundred and twenty six pregnancies have been tested so far in these 5 years. Neither false positives nor false negatives diagnoses have been registered, thus giving a diagnostic accuracy of 100%.
Keywords: non-invasive prenatal diagnosis; fetal DNA; maternal plasma; fetal sex determination non-invasive prenatal diagnosis; fetal DNA; maternal plasma; fetal sex determination
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Export to BibTeX |
EndNote


MDPI and ACS Style

Perlado-Marina, S.; Bustamante-Aragones, A.; Horcajada, L.; Trujillo-Tiebas, M.J.; Lorda-Sanchez, I.; Ruiz Ramos, M.; Plaza, J.; Rodriguez de Alba, M. Overview of Five-Years of Experience Performing Non-Invasive Fetal Sex Assessment in Maternal Blood. Diagnostics 2013, 3, 283-290.

AMA Style

Perlado-Marina S, Bustamante-Aragones A, Horcajada L, Trujillo-Tiebas MJ, Lorda-Sanchez I, Ruiz Ramos M, Plaza J, Rodriguez de Alba M. Overview of Five-Years of Experience Performing Non-Invasive Fetal Sex Assessment in Maternal Blood. Diagnostics. 2013; 3(2):283-290.

Chicago/Turabian Style

Perlado-Marina, Sara; Bustamante-Aragones, Ana; Horcajada, Laura; Trujillo-Tiebas, Maria J.; Lorda-Sanchez, Isabel; Ruiz Ramos, Marta; Plaza, Javier; Rodriguez de Alba, Marta. 2013. "Overview of Five-Years of Experience Performing Non-Invasive Fetal Sex Assessment in Maternal Blood." Diagnostics 3, no. 2: 283-290.

Diagnostics EISSN 2075-4418 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert